U.S. Capital Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CRM
U.S. Capital Wealth Advisors's LMAT Position: Q1 2023 in Review
U.S. Capital Wealth Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 311 shares — an estimated $14.3K sold.
U.S. Capital Wealth Advisors first reported a position in LMAT in Q4 2022 and held it in 1 quarter. The position peaked at $14.3K in Q4 2022. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.
- U.S. Capital Wealth Advisors reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
- U.S. Capital Wealth Advisors sold 311 LeMaitre Vascular shares in Q1 2023, an estimated $14.3K.
- U.S. Capital Wealth Advisors first reported a position in LeMaitre Vascular in Q4 2022 and held it in 1 quarter.
- U.S. Capital Wealth Advisors's LeMaitre Vascular position peaked at $14.3K in Q4 2022.
- 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.
Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.